Every year, more than 3,000 scientific abstracts are accepted for oral and poster presentation at the Society's annual meeting.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
Advance registration for the 56th ASH® Annual Meeting is now open.
December 7, 2014 - run or walk in the ASH Foundation 3K - 5K Run/Walk and help move hematology forward.
Now offering malignant and non-malignant hematology testing modules that provide both MOC and CME credit
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research.
Search a database of practicing hematologists in your area.
Help move hematology forward by supporting research, career development, and quality care and education programs.
Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.
The American Society of Hematology (ASH) today
announced the 20 hematologists and other medical professionals selected to
participate in the 2014 ASH Visitor Training Program. This program provides
talented hematologists, scientists, and laboratory staff from developing
countries the opportunity to receive training on a specific area of hematology
from an ASH member located anywhere in the world for up to 12 weeks. The goal
of this program is to build hematology capacity in developing countries and
ultimately improve the care of patients with blood diseases worldwide.
The American Society
of Hematology (ASH), the world’s largest professional society concerned with
the causes and treatment of blood disorders, today joins the International
Society on Thrombosis and Haemostasis (ISTH) and nearly 200 organizations
worldwide to commemorate October 13, 2014, as the inaugural World Thrombosis
Day, a day dedicated to raising awareness of potentially dangerous blood clots.
Today the Centers
for Medicare & Medicaid Services released a large set of data about
the payments physicians and teaching hospitals received from pharmaceutical and
medical device companies from August 1 to December 31, 2013.
American Society of Hematology (ASH) today announced the names of the 21
hematology trainees selected to participate in the 12th annual ASH Clinical
Research Training Institute (CRTI).
This education and mentorship program is designed to prepare current hematology
and hematology/oncology fellows and junior faculty for careers in
patient-oriented clinical research.
The Medicare Payment
Advisory Commission (MedPAC) is an advisory body to Congress that meets seven
times a year. They offer recommendations to Congress on the various payment
systems within Medicare, as well as monitor more focused topics of their
choosing. During the most recent meeting on October 9, MedPAC analyzed data on
opioid abuse for Medicare Part D enrollees.
Both the findings and potential policy implications could affect
practicing hematologists who routinely prescribe opioids.
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) and Office of the Assistant Secretary for Preparedness and Response (ASPR) continues to respond to the current Ebola outbreak in West Africa. The CDC has summarized key messages about the outbreak and the response, and it will continue to update its resources as more information becomes available.
On September 30 at
around 2PM, the Centers for Medicare and Medicaid Services (CMS) publicly
released the data that it had been gathering from pharmaceutical and medical
device companies that detail value transfers to physicians and medical schools. ASH has been keeping members apprised of
these developments since this provision was included in the Affordable Care
The Medicare Payment
Advisory Commission (MedPAC) used its second session of the 2014-2015 cycle to
take on an issue that could be very important for hematologists and access to
drugs for their patients–the opportunity for Medicare to pay for drugs on a “least costly alternative” basis. ASH continues to
follow this issue as part of a commitment to ensure that policies are created
that give patients efficient access to important drugs while maintaining
clinician decision-making and incentives for continued innovation.
Dr. Bertuch and Dr. Kurre examine the need for improvement in how acquired aplastic anemia is both diagnosed and treated in the United States.
This fall, ASH will begin publishing a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology. ASH Clinical News will provide timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature.
Dr. Gilbert White chronicles his involvement in the HIV and HCV epidemics that devastated the hemophilia population in the 1980s, highlighting the power of science and the resilience of patients, physicians, and scientists, who faced adversity and triumphed.
It's not to early to plan to attend the annual meeting. Read about what's in store for this year's program.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology